The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Return to intended oncologic therapy in patients with metastatic non-small cell lung cancer discharged to a skilled nursing facility.
 
Anirudh Yalamanchali
No Relationships to Disclose
 
Preeyal Patel
No Relationships to Disclose
 
Ali Mushtaq
No Relationships to Disclose
 
Nathan Pennell
Consulting or Advisory Role - Anheart Therapeutics; bristol-myers sqibb; ConcertAI; Daiichi Sankyo; Genentech; Iovance Biotherapeutics; Janssen Oncology; Lilly; ResistanceBio; Takeda; Vial
Research Funding - Advenchen Laboratories (Inst); Anheart Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); InhibRx (Inst); Loxo (Inst); Merck (Inst); Mirati Therapeutics (Inst); Navire (Inst); Puma Biotechnology (Inst); Seattle Genetics/Astellas (Inst); Summit pharmaceuticals (Inst)